Form 4: Amprius Technologies Executive Exercises Stock Options and Acquires Shares

Jonathan Bornstein, President of Amprius Lab, exercised stock options and acquired shares of Amprius Technologies common stock on March 10, 2025.

Summary

• On March 10, 2025, Jonathan Bornstein, President of Amprius Lab at Amprius Technologies, exercised stock options to acquire 3,471 shares of common stock at a price of $0.98 per share.
• Following the transaction, Bornstein directly owns 422,668 shares of Amprius Technologies common stock, which includes 419,197 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The exercise of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their holdings of company stock.

Stakeholder Impact

• The transaction may have a minor impact on shareholders by slightly increasing the number of outstanding shares.

Key Dates